Two Sigma Investments’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.36M	Buy	482,136 +424,353	+734%	+$5.36M	﹤0.01%	1929
2025 Q4	$959K	Buy	+57,783	New	+$825K	﹤0.01%	2945
2025 Q2	–	Sell	-97,327	Closed	-$610K	–	3446
2025 Q1	$610K	Sell	97,327 -388,463	-80%	-$2.36M	﹤0.01%	2435
2024 Q4	$3.94M	Buy	485,790 +331,760	+215%	+$4.11M	0.01%	1252
2024 Q3	$2.78M	Sell	154,030 -149,401	-49%	-$2.09M	0.01%	1468
2024 Q2	$3.13M	Sell	303,431 -164,017	-35%	-$1.69M	0.01%	1255
2024 Q1	$4.96M	Buy	467,448 +200,591	+75%	+$1.7M	0.01%	976
2023 Q4	$2.44M	Buy	266,857 +182,794	+217%	+$1.57M	0.01%	1387
2023 Q3	$872K	Buy	84,063 +42,563	+103%	+$584K	﹤0.01%	2013
2023 Q2	$594K	Buy	41,500 +12,400	+43%	+$143K	﹤0.01%	2252
2023 Q1	$208K	Buy	+29,100	New	+$256K	﹤0.01%	2540
2022 Q3	–	Sell	-35,304	Closed	-$298K	–	2727
2022 Q2	$298K	Sell	35,304 -4,912	-12%	-$50.5K	﹤0.01%	2028
2022 Q1	$547K	Sell	40,216 -23,580	-37%	-$381K	﹤0.01%	1976
2021 Q4	$1.25M	Buy	63,796 +41,241	+183%	+$971K	﹤0.01%	2350
2021 Q3	$724K	Sell	22,555 -17,429	-44%	-$579K	﹤0.01%	2924
2021 Q2	$1.35M	Sell	39,984 -14,671	-27%	-$525K	﹤0.01%	2214
2021 Q1	$2.05M	Buy	+54,655	New	+$2.29M	0.01%	1691